Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00535587 · ClinicalTrials.gov registry record · Phase 2
Testing Mestinon and Exercise in Fibromyalgia
A Phase 2 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 2
- Development phase
- 178
- Enrollment target
NCT00535587 is a Phase 2 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 178 participants.
The verdict
NCT00535587, a Phase 2 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 178 participants
- Enrollment target
Study Summary
The purpose of this trial was to test the combined and independent effects of 6 months of exercise and Mestinon in people with fibromyalgia. Specifically, we wanted to determine if Mestinon helped people with fibromyalgia have an easier time exercising and if their symptoms improved by the end of the trial.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Exercise
- DRUG pyridostigmine
- DRUG Placibo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2002-09 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00535587
The ClinicalTrials.gov registry entry for NCT00535587 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Attention Control is the first listed.
NCT00535587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00535587 about?
NCT00535587 is a clinical study titled "Testing Mestinon and Exercise in Fibromyalgia". The purpose of this trial was to test the combined and independent effects of 6 months of exercise and Mestinon in people with fibromyalgia. Specifically, we wanted to determine if Mestinon helped people with fibromyalgia have an easier time exercising and if their symptoms improved by the end of th...
What is the current status of trial NCT00535587?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 178 participants. The study started on 2002-09. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00535587?
The interventions under investigation include: Attention Control (BEHAVIORAL), Exercise (BEHAVIORAL), pyridostigmine (DRUG), Placibo (DRUG).
Who is sponsoring clinical trial NCT00535587?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.